Skip to main content

Table 3 Distribution of baseline characteristics among subjects with different frailty categories

From: Performance of Edmonton Frail Scale on frailty assessment: its association with multi-dimensional geriatric conditions assessed with specific screening tools

 

No frailty

(≤5 points)

Apparently vulnerable

(6 ≤ n ≥ 11 points)

Severe frailty

(12 ≤ n ≥ 17)

 

(Mean ± SD)

(Mean ± SD)

(Mean ± SD)

P value

Age, years

78.93 ± 7.19

81.80 ± 6.41

82.92 ± 5.47

p<0.001

Body Mass Index (kg/m2)

24.96 ± 4.17

25.16 ± 5.01

24.85 ± 5.46

0.922

Assessment of functional performance

 Hand Grip DX, kg

19.10 ± 6.43

16.21 ± 6.15

14.12 ± 5.73

p<0.05

 Bartel Index, points

75,38 ± 21,85

61,6 ± 23,81

51 ± 26,80

p<0.001

Assessment of cognitive status and mood

 MMSE, points

20.54 ± 5.86

18.37 ± 6.01

15.1 ± 7.05

p<0.001

 GDS, points

7.57 ± 3.70

5.52 ± 3.49

4.60 ± 2.61

p<0.001

Assessment of general health status

 Drugs, n

7,62 ± 3,42

8,77 ± 3,34

9,38 ± 2,92

p<0.05

 Diseases, n

5.43 ± 2,42

5,95 ± 2,77

6,92 ± 3,20

p<0.05

Assessment of living independence

 ADL, points

4,28 ± 1,69

3,10 ± 1,75

2,25 ± 1,79

p<0.001

Assessment of sarcopenia

 SMI, n

6.96 ± 1.22

6.75 ± 1.28

6.48 ± 1.06

0.194

Assessment of osteoporosis

 BMD, g/cm2

0.81 ± 0.14

0.77 ± 0.17

0.73 ± 0.16

p<0.05

 T-SCORE, points

−1.79 ± 0.96

−2.02 ± 1.35

−2.41 ± 1.33

p<0.05

Assessment of proteinuria

 Albumin, g/dl

3.73 ± 0.44

3.64 ± 0.50

3.62 ± 0.44

0.079

 MNA, points

20,33 ± 3,35

17,96 ± 3,13

15,48 ± 3,11

p<0.001